Patents
Patents for C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
11/2004
11/17/2004EP1476438A1 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
11/17/2004EP1476419A2 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
11/17/2004CN1546477A Method for preparing electron transport / hole barrier material and its electro-glow parts
11/11/2004WO2004096948A1 Electron transport agents for organic electronic devices
11/11/2004WO2004096783A1 Ethynyl containing electron transport agents and their use in organic luminescent devices
11/11/2004WO2004067675A3 Binaphthol based chromophores for the fabrication of blue organic light emitting diodes
11/11/2004WO2004065360A3 Piperazine derivatives and their use as synthesis intermediates
11/10/2004EP1475371A1 1-substituted-1-aminomethyl-cycloalkane derivatives (= gabapentin analogues), their preparation and their use in the treatment of neurological disorders
11/10/2004CN1544420A Inhibition of raf kinase using substituted heterocyclic ureas
11/04/2004WO2004080377A3 Kcnq channel modulating compounds and their pharmaceutical use
11/04/2004WO2004067506A3 Substituted heterocyclic compounds
11/04/2004WO2003087044A3 Novel carboxamide compounds for use in mch receptor related disorders
11/04/2004US20040220411 Oxalic acid derivatives
11/04/2004US20040220225 Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications
11/04/2004US20040220193 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
11/03/2004EP1472214A2 Compounds for inhibiting insulin secretion and methods related thereto
11/03/2004CN1173944C New vitamin-D derivatives with carbon ring or heterocyclic substitutents at C-25, process for the preparation, intermediate products and their use for producing medicaments
11/02/2004CA2320676C Process and intermediates for the preparation of aminotriazine derivatives
10/2004
10/28/2004WO2004092116A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
10/28/2004WO2004091502A2 1,2,4-oxadiazole benzoic acid compounds
10/28/2004US20040214827 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants
10/28/2004US20040214037 a compound having a trivalent carbocyclic aromatic core attached to at least two ethynyl groups and side chains with heteroaryl rings; electroluminescent devices
10/28/2004US20040214036 Electron transport agents for organic electronic devices
10/28/2004CA2521937A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
10/27/2004EP1471064A1 Coumarin derivatives, process for their production and use thereof
10/27/2004EP1471049A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
10/27/2004CN1541211A Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same
10/21/2004WO2004089874A1 Biphenyl carboxylic amide p38 kinase inhibitors
10/21/2004WO2004014370A3 Oxadiazoles as modulators of metabotropic glutamate receptor-5
10/21/2004CA2521228A1 Biphenyl carboxylic amide p38 kinase inhibitors
10/20/2004EP1467989A1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatitis c virus infection
10/14/2004WO2004087684A1 Benzo[1,2,5]oxadiazoles and benzo [1,2,5]thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers
10/14/2004WO2004004655A3 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
10/14/2004WO2004000785A3 Phenyloxyalkanonic acid derivatives as hppar activators
10/14/2004US20040204477 For use as antiproliferative agents
10/14/2004US20040204461 1,2,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease
10/14/2004US20040204368 Oxadiazole derivative compounds and drugs containing these compounds as the active ingredient
10/14/2004CA2520278A1 Benzo[1,2,5]oxadiazoles and benzo [1,2,5]thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers
10/13/2004EP1466891A1 Carboxylic acid derivative
10/13/2004EP1465861A1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
10/13/2004CN1170813C N2 phenylamidine derivatives and fungicidal composition and use
10/12/2004US6803381 Carbamic acid derivatives
10/12/2004CA2170394C Process for conditioning substances
10/07/2004WO2004085411A1 Non-nucleoside reverse transcriptase inhibitors i for treating hiv mediated diseases
10/07/2004US20040198982 such as (4S)-1-(3-bromophenyl)-N-cyanomethyl)-4-methyl-prolinamide; for treatment of osteoporosis
10/07/2004US20040197879 1,2,3,4-tetrazol-1-yl-L-alanine or 1,2,3,4-tetrazol-2-yl-L-alanine.
10/06/2004EP1463715A1 Novel glucagon antagonists
09/2004
09/30/2004WO2004083194A1 Blue light-emitting compound, method for producing same and light-emitting device utilizing same
09/30/2004WO2003072535A8 Substituted hydroxyethylamines
09/30/2004US20040192779 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
09/30/2004US20040192704 Non-nucleoside reverse transcriptase inhibitors
09/29/2004CN1533388A Substituted piperazine compounds and their use as fatty acid oxidation inhibitors
09/28/2004US6797720 1,3,4-oxadiazoline derivative and an agent comprising its derivative as active ingredient
09/23/2004WO2004080958A2 Process to tetrahydrotriazolopyrazines and intermediates
09/23/2004WO2004080377A2 Kcnq channel modulating compounds and their pharmaceutical use
09/23/2004US20040186178 Amidino compounds useful as nitric oxide synthase inhibitors
09/22/2004EP1458676A2 Compounds for the treatment of inflammatory disorders
09/22/2004EP1100503B1 Non-imidazole alkylamines as histamine h 3?-receptor ligands and their therapeutic applications
09/21/2004CA2114017C Amide tetrazole acat inhibitors
09/16/2004WO2004078734A1 TETRAZOLE AND OXADIAZOLONE SUBSTITUTED β-AMINO ACID DERIVATIVES
09/16/2004WO2004064972A9 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
09/16/2004WO2004033652A3 Inhibitors of fatty acid amide hydrolase
09/16/2004CA2518218A1 Tetrazole and oxadiazolone substituted .beta.-amino acid derivatives
09/15/2004EP1456216A1 Use of metal complex compounds as oxidation catalysts
09/15/2004EP1456186A1 Novel inhibitor compounds specific of secreted non-pancreatic human a sb 2 /sb phospholipase of group ii
09/15/2004EP1455777A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
09/15/2004CN1529695A Anthranilic acid amides with heteroarylsulfonyl side chain, method for production thereof, use thereof as medicament or diagnostic agent and phamaceutical preparations containing same
09/10/2004WO2004076420A1 Heteroarylcarbamoylbenzene derivative
09/10/2004CA2516407A1 Heteroarylcarbamoylbenzene derivatives
09/09/2004US20040176595 Glucocorticoid receptor modulators
09/09/2004US20040176461 Sulfonyl-amino or carbonyl-amino derivatives; osteoporosis bone disorders; therapeutic drug or kits including anti-resorptive agents, anabolic agents;
09/09/2004US20040176374 Arylsulfonamides as antiviral agents
09/08/2004EP1453789A2 N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/08/2004EP1047678B1 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
09/02/2004WO2004073606A2 Sulfonamide derivatives as ppar modulators
09/02/2004US20040171881 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/02/2004US20040171651 Regulating and tailoring expression levels; such as N-[3-(4-chloro-phenyl)-5,5-dimethyl-[1,2,4]oxadiazol-4-yl]-3-ethyl-benzamide
09/02/2004US20040171491 Substituted benzoylcyclohexenones and their use as herbicidal agents
09/02/2004CA2512883A1 Sulfonamide derivatives as ppar modulators
09/01/2004EP1451276A1 1,3,4-oxadiazole additives for lubricants
09/01/2004EP1451162A1 Substituted diphenyl heterocycles useful for treating hcv infection
09/01/2004CN1525959A Muller Klaus-helmut
08/2004
08/31/2004US6783949 Reacting fluorescently labeled fatty acid with 2,3-epoxypropanol to form monoglyceride which is subjected to ultrasonic treatment with phospholipids; drug screening; for detecting metabolic disorders
08/26/2004WO2004072050A1 Heterocyclic compounds useful as nurr-1 activators
08/26/2004WO2004018461A3 Antibacterial benzoic acid derivatives
08/26/2004WO2004013094A3 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
08/26/2004WO2004003102A3 Polymerizable, luminescent compounds and mixtures, luminescent polymer materials and their use
08/26/2004US20040167116 Viricides
08/26/2004DE10306503A1 New 1-benzoyl-3-(heterocyclyl-phenyl)-urea derivatives, are glycogen phosphorylase a inhibitors useful e.g. for treating type II diabetes, dyslipidemia or arteriosclerosis
08/26/2004CA2515847A1 Heterocyclic compounds useful as nurr-1 activators
08/25/2004EP1448538A1 Peroxisome proliferator activated receptor alpha agonists
08/25/2004EP1149069B1 Phenylglycine derivatives
08/25/2004CN1524072A Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours
08/19/2004WO2004069823A1 Inhibitors of histone deacetylase
08/19/2004WO2004048335A3 Mandelic acid derivatives
08/19/2004WO2004046090A3 Aryl ureido derivatives and their medical use
08/18/2004EP1446399A1 Piperazine derivatives having sst1 antagonistic activity
08/18/2004EP1446392A1 Oligopeptides and compositions containing them as cathepsin s inhibitors
08/18/2004EP1446385A1 Preparation and use of substituted imidazoles
08/18/2004EP1446375A1 Dihalogenpropene compounds, method for the production thereof, agents containing said compounds and the use thereof as pest control agents
1 ... 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 ... 72